THURSDAY, DECEMBER 13, 2018

Similar documents
THURSDAY, DECEMBER 13, 2018

7:40-7:50 Radical Prostatectomy Technique for Preservation of Urinary Continence and The Pagano Suture John Libertino, MD

FRIDAY, DECEMBER 14, 2018

AGENDA. 7:40 am - 7:50 am Radical Prostatectomy Technique for Preservation of Urinary Continence and The Pagano Suture John Libertino, MD

AGENDA. 8:05 am - 8:15 am Radical Prostatectomy Technique for Preservation of Urinary Continence and The Pagano Suture John Libertino, MD

FRIDAY, DECEMBER 14, 2018

Dear Industry Colleagues:

PRACTICAL Urology. USC Institute of Urology 4 th Annual Conference: Guest Faculty. Thursday January 31, January 31, February 1 2, 2019

6 TH INTERNATIONAL TECHNO-UROLOGY MEETING (TUM) NEW TECHNOLOGIES FOR A MORE PRECISE SURGERY

Saturday, 13 February 2016

Mayo Clinic Update in Urology 2017: February 20-24, 2017 Atlantis, Paradise Island Bahamas

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

FEBRUARY 4 6, Aresty Auditorium, USC Health Science Campus PROSTATE CANCER

Patterns of care for prostate cancer An update

State-of-the-art: vision on the future. Urology

6th ESUR Teaching Course on Prostate MRI, Berlin 2016

URO. THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer MADRID SEPTEMBER Hospital Universitario Puerta de Hierro Majadahonda

Urology Update. Mount Sinai First to Test Gold Nanoparticle Treatment for Prostate Cancer. Insights from Dr. Ash Tewari, Chair. more updates inside:

Programme - Friday, 7 September

ESOU programme Prostate cancer screening: Why screening programme should not be adopted in > 65 A. Heidenreich, Aachen (DE)

Prostate & Urologic Cancers Symposium

Prostate Cancer Dashboard

Genitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General

URO-ONCOLOGY DIALOGUE

AllinaHealthSystems 1

January 10-12, Westin Harbour Castle Toronto, ON #CUOS19. cuos2019.org

16:30-18:30 WS #67: Urology Forum - Prostate Cancer, Stones, Renal Tumours, Voiding Dysfunction (120 minutes, not repeated) -

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director

Department of Urology, Cochin hospital Paris Descartes University

Screening and Diagnosis Prostate Cancer

Friday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)

8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)

Personalized Therapy for Prostate Cancer due to Genetic Testings

Optimising Prostate Cancer Diagnostics

Prostatic Cryosurgery and Robotic Prostatectomy

Trends in Prostate Cancer Bob Weir AVP Underwriting Research Canada Life Reinsurance

in Laparoscopy The European Congress of Laparoscopy 2007 Bordeaux, France Palais des Congres

Case Discussions: Prostate Cancer

About the authors Dr S. Larry Goldenberg Dr Tom Pickles Dr Kim N. Chi

[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK

Asian Urology Residents' Course 2018 Program

Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer

4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France

SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING ADVANCES IN

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES

Programme. Day -2 5 th August 2019 Monday. Day -1 6 th August 2019 Tuesday. Day 0 7 th August 2019 Wednesday

CITY OF HOPE PROSTATE CANCER OUTCOME SUMMARY

Prostate Cancer. David Wilkinson MD Gulfshore Urology

Your Guide to Prostate Cancer

Quality of Life with an Aging Prostate: The Sperling Prostate Center Protocol. Dan Sperling, MD, DABR The Sperling Prostate Center Delray Beach, FL

Effective Date: 11/1/2018 Section: SUR Policy No: 420 Medical Policy Committee Approved Date: 8/18; 9/18

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B

Controversy Surrounds Question of Who Needs to be Treated for Prostate Cancer No One Size Fits All Diagnosis or Treatment

Thursday 15 September

Comparative Effectiveness Research of Robotic Surgeries for Cancer Treatment

PAUL PETERS 2018 PROGRAM. 9:20am Reconstructive Urology Case Discussion Maxim McKibben MD, Joceline Fuchs MD, Allen Morey MD (moderator)

Melanoma Summit. DRAFT programme. New Zealand November 2018 Cordis Hotel, Auckland. As at 27 June Subject to change.

2019 Mayo Clinic Urology Review Program Schedule

PROGRAMME DRAFT. September 18 th to 20 th 2008

Date Modified: May 29, Clinical Quality Measures for PQRS

Around the Kidney MILAN INTERNATIONAL SURGERY, KNOWLEDGE, AND TECHNOLOGY

NICE BULLETIN Diagnosis & treatment of prostate cancer

MR-US Fusion. Image-guided prostate biopsy. Richard E Fan Department of Urology Stanford University

Prostate Cancer: from Beginning to End

The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida

Melanoma Summit. DRAFT programme. New Zealand November 2018 Cordis Hotel, Auckland. As at 1 September Subject to change.

Friday, 24 October 2014

Role of surgery. Theo M. de Reijke MD PhD FEBU Department of Urology Academic Medical Center Amsterdam

PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?

Providing Treatment Information for Prostate Cancer Patients

Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps?

7 TH INTERNATIONAL TECHNO-UROLOGY MEETING (TUM) AUGMENTED REALITY AND BEYOND: THE FUTURE IS NOW!

Cliniques universitaires Saint Luc

Urologic Oncology Section

Appendix 4 Urology Care Pathways

Capital Health s 6 th Annual National Neuroscience Conference (Updated 8/25/14) October 22-24, 2014 Bally s Atlantic City

Prostate Case Scenario 1

Thursday 19 October 2017

HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA

PSA is rising: What to do? After curative intended radiotherapy: More local options?

Definition Prostate cancer

Localized Prostate Cancer and Its Treatment- A Patient Guide

Can men on AS be treated with testosterone?

The Role of the Pathologist Active Surveillance for Prostate Cancer

Prostate Cancer Treatment Decision Information Background

55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing

AGENDA: FEBRUARY 22, 2018 INTRODUCTION

AAOS/ASES Management of Massive Rotator Cuff Tears: Repair to Replacement PROGRAM SCHEDULE

Programme. Day -2 5 th August 2019 Monday. Day -1 6 th August 2019 Tuesday. Day 0 7 th August 2019 Wednesday

International Symposium Features Renowned Faculty Experts and Complex Live Surgeries

Prostate Cancer: 2010 Guidelines Update

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme

Robotics, Laparoscopy & Endosurgery

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

Focal Therapy is a Fool s Paradise : The whole prostate must be treated!

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed

ISSM, and AUA meetings is expected.

Clinical/Surgical trials that will change my practice

Prostate Cancer Incidence

Transcription:

THURSDAY, DECEMBER 13, 2018 7:00 am Welcome and Introduction 7:10 am The Hans E. Shapira Lecture Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Peter Scardino, MD EPIDEMIOLOGY AND EARLY DIAGNOSIS OF PROSTATE CANCER (PART 1) Panelists: Giuseppe Carrieri, MD; Philippa Cheetham, MD; Ralph Clayman, MD 7:40 am Management of Diet, Exercise on Prostate John Kellogg Parsons, MD 8:00 am 3D Live Surgery: Robot Assisted Radical Prostatectomy Surgeon: Moderators: Ketan K. Badani, MD; Alberto Martini, MD Panelists: Fabrizio Dal Moro, MD; Francesco Montorsi, MD; Alexandre Mottrie, MD, PhD; Peter Scardino, MD 9:30 am Q&A for Live Surgery 9:45 am Radiotherapy Michael Zelefsky, MD 10:00 am Emperor of All Maladies: Cancer and the Implications for Prostate Cancer Siddhartha Mukherjee, MD Featured Guest Speaker 11:00 am Coffee Break EPIDEMIOLOGY AND EARLY DIAGNOSIS OF PROSTATE CANCER (PART 2) Panelists: TBD 11:10 am Biomarkers in Prostate Cancer Christopher Evans, MD 11:20 am Imaging in Prostate Cancer Art Rastinehad, DO 11:35 am Introduction to Sit-Down MRI Trial Page 1/15

11:45 am Targeted-Biopsy Techniques Samir Taneja, MD 12:00 pm When to Skip Biopsy: Before Diagnosis, During AS, Follow-Up of FT Arnauld Villers, MD, PhD 12:10 pm How Has the Task Force Hurt Cancer Screening? Jim Hu, MD, MPH 12:20 pm Q&A (Epidemiology and Early Diagnosis of Prostate Cancer (Part 2) 12:30 pm LUNCH SYMPOSIUM MAIN AFTERNOON SESSION STAGING, IMAGING, AND GENOMICS Panelists: Christopher Barbieri, MD, PhD; Francesco Montorsi, MD; Alexandre Mottrie, MD, PhD; Kenneth Rosenzweig, MD 1:30 pm In Search of a Man Eater 1:50 pm Genomic Landscape of Prostate Cancer Arul Chinnaiyan, MD, PhD 2:20 pm Current Status of Nomograms and Imaging Markers in Prostate Cancer Christopher Barbieri, MD, PhD 2:30 pm Genomics in Prostate Cancer Christopher Evans, MD 2:45 pm Q&A (Staging, Imaging and Genomics) 2:55 pm DEBATE Imaging is More Appropriate for Identifying Unfavorable Pathology in Early Prostate Cancer - Art Rastinehad, DO Genomics is Best for Identifying Unfavorable Pathology in Early Prostate Cancer (TBD) MANAGEMENT OF VERY LOW RISK AND LOW RISK PROSTATE CANCER Panelists: John Denstedt; Lee Richstone, MD; Atsushi Takenaka, MD, PhD 3:25 pm New Anatomy of Prostate for Robotic Prostatectomy Page 2/15

4:10 pm Anatomical Prostatectomy Thomas Bessede, MD 4:25 pm Management of BPH in Active Surveillance Patients Steven Kaplan, MD 4:35pm Q&A (Management of Very Low Risk and Low Risk Prostate Cancer) BEST TREATMENT FOR AGGRESSIVE PROSTATE CANCER Panelists: Bobby Liaw, MD; Daniel W. Lin, MD; William Oh, MD; Peter Scardino, MD 4:45 pm State of ART Lecture Innovative Drug Development and the Academic Urologic Oncologist: A Personal Experience Arie Belldegrun, MD FOCAL THERAPY Panelists: Jonathan Coleman, MD; Jim Hu, MD; Aaron Katz, MD; Art Rastinehad, DO 5:15pm Focal Therapy: Is It Ready for Prime Time? Herbert Lepor, MD 5:30 pm Focal Therapy for Prostate Cancer Art Rastinehad, DO 5:40 pm Partial Gland Ablation and Focal Therapy for Prostate Cancer Jonathan Coleman, MD 5:50 pm The Role of Salvage Cryotherapy and the Outcomes Aaron Katz, MD 6:00 pm Complications of Focal Therapy Rene Javier Sotelo, MD SURGICAL TREATMENT OF INTERMEDIATE RISK PROSTATE CANCER Panelists: Markus Hohenfellner, MD; Prasanna Sooriakumaran, MD, PhD 6:10pm QOL Comparison Between Open vs Robotic Prostatectomy Misop Han, MD 6:20 pm Metastatic Hormone Sensitive Prostate Cancer: What the Urologist Needs to Know Michael Cookson, MD 6:30 pm RARP: Surgical Steps for Better Oncological and Functional Outcomes Jorn Witt, MD Page 3/15

6:40 pm Global Perspectives in Robotic Surgery: A Healthy Market is a Competitive One Maurizio Buscarini, MD 6:50 pm Q&A (Surgical Treatment of Intermediate Risk Prostate Cancer) 7:00 pm Conclusion Page 4/15

THURSDAY, DECEMBER 13, 2018 BREAKOUT SESSION: IMMUNOTHERAPY & TUMOR MICROENVIRONMENT (PART I) Moderators: Arie Belldegrun, MD; Nina Bhardwaj, MD, PhD 1:30 pm Cancer Immunotherapy and Targeting Innate Immune Cells Nina Bhardwaj, MD, PhD 1:40 pm Q&A (Cancer Immunotherapy and Targeting Innate Immune Cells) 1:43 pm Prostate Cancer Radiomics Study Stefanie Hectors, PhD 1:53 pm Q&A (Prostate Cancer Radiomics) 1:56 pm Targeting DNA Repair Deficiency in Prostate Cancer Joseph W. Kim, MD 2:06 pm Q&A (Targeting DNA Repair Deficiency in Prostate Cancer) 2:09 pm PRINT Study Discussion Bobby Liaw, MD 2:19 pm Q&A PRINT Study Discussion 2:22 pm Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced Prostate Cancer: Opportunities for Personalized Care Aria Olumi, MD 2:32 pm Q&A (Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced Prostate Cancer: Opportunities for Personalized Care) 2:35 pm Combination Immunotherapy Strategies Ravi Madan, MD 2:45 pm Q&A (Combination Immunotherapy Strategies) 2:48 pm A Pragmatic Approach to Radiation Strictures Jerry Blaivas, MD 2:58 pm Q&A (A Pragmatic Approach to Radiation Strictures) Page 5/15

3:01 pm Urethral Strictures Rajveer S. Purohit, MD 3:11 pm Q&A (Management of Incontinence after Radiation or Surgery) 3:14 pm Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of Post-Prostatectomy Incontinence Neil H. Grafstein, MD 3:24 pm Q&A (Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of Post-Prostatectomy Incontinence) 3:27 pm Treatment of Male Hypogonadism Using Non-Testosterone Therapies Natan Bar-Chama, MD 3:37 pm Q&A (Treatment of Male Hypogonadism Using Non-Testosterone Therapies) 3:40 pm Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site Daniel Gainsburg, MD 3:50 pm Q&A (Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site) 3:53 pm Quality of Life after Urologic Cancer Nihal Mohamed, PhD 4:03 pm Q&A (Quality of Life after Urologic Cancer) 4:06 pm Advances in Artificial Intelligence Applied to Prostate Cancer Gerardo J. Fernandez, MD 4:16pm Q&A (Advances in Artificial Intelligence Applied to Prostate Cancer) 4:19 pm Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy Using CyberKnife Jonathan Haas, MD 4:29 pm Q&A (Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy Using CyberKnife) 4:31 pm JOIN THE MAIN SESSION Page 6/15